Cargando…
Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice
The intestinal microbiota and fecal metabolome have been shown to play a vital role in human health, and can be affected by genetic and environmental factors. We found that individuals with Down syndrome (DS) had abnormal serum cytokine levels indicative of a pro-inflammatory environment. We investi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998045/ https://www.ncbi.nlm.nih.gov/pubmed/36910172 http://dx.doi.org/10.3389/fmicb.2023.1016872 |
_version_ | 1784903390231265280 |
---|---|
author | Cai, Shaoli Lin, Jinxin Li, Zhaolong Liu, Songnian Feng, Zhihua Zhang, Yangfan Zhang, Yanding Huang, Jianzhong Chen, Qi |
author_facet | Cai, Shaoli Lin, Jinxin Li, Zhaolong Liu, Songnian Feng, Zhihua Zhang, Yangfan Zhang, Yanding Huang, Jianzhong Chen, Qi |
author_sort | Cai, Shaoli |
collection | PubMed |
description | The intestinal microbiota and fecal metabolome have been shown to play a vital role in human health, and can be affected by genetic and environmental factors. We found that individuals with Down syndrome (DS) had abnormal serum cytokine levels indicative of a pro-inflammatory environment. We investigated whether these individuals also had alterations in the intestinal microbiome. High-throughput sequencing of bacterial 16S rRNA gene in fecal samples from 17 individuals with DS and 23 non-DS volunteers revealed a significantly higher abundance of Prevotella, Escherichia/Shigella, Catenibacterium, and Allisonella in individuals with DS, which was positively associated with the levels of pro-inflammatory cytokines. GC-TOF-MS-based fecal metabolomics identified 35 biomarkers (21 up-regulated metabolites and 14 down-regulated metabolites) that were altered in the microbiome of individuals with DS. Metabolic pathway enrichment analyses of these biomarkers showed a characteristic pattern in DS that included changes in valine, leucine, and isoleucine biosynthesis and degradation; synthesis and degradation of ketone bodies; glyoxylate and dicarboxylate metabolism; tyrosine metabolism; lysine degradation; and the citrate cycle. Treatment of mice with fecal bacteria from individuals with DS or Prevotella copri significantly altered behaviors often seen in individuals with DS, such as depression-associated behavior and impairment of motor function. These studies suggest that changes in intestinal microbiota and the fecal metabolome are correlated with chronic inflammation and behavior disorders associated with DS. |
format | Online Article Text |
id | pubmed-9998045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99980452023-03-10 Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice Cai, Shaoli Lin, Jinxin Li, Zhaolong Liu, Songnian Feng, Zhihua Zhang, Yangfan Zhang, Yanding Huang, Jianzhong Chen, Qi Front Microbiol Microbiology The intestinal microbiota and fecal metabolome have been shown to play a vital role in human health, and can be affected by genetic and environmental factors. We found that individuals with Down syndrome (DS) had abnormal serum cytokine levels indicative of a pro-inflammatory environment. We investigated whether these individuals also had alterations in the intestinal microbiome. High-throughput sequencing of bacterial 16S rRNA gene in fecal samples from 17 individuals with DS and 23 non-DS volunteers revealed a significantly higher abundance of Prevotella, Escherichia/Shigella, Catenibacterium, and Allisonella in individuals with DS, which was positively associated with the levels of pro-inflammatory cytokines. GC-TOF-MS-based fecal metabolomics identified 35 biomarkers (21 up-regulated metabolites and 14 down-regulated metabolites) that were altered in the microbiome of individuals with DS. Metabolic pathway enrichment analyses of these biomarkers showed a characteristic pattern in DS that included changes in valine, leucine, and isoleucine biosynthesis and degradation; synthesis and degradation of ketone bodies; glyoxylate and dicarboxylate metabolism; tyrosine metabolism; lysine degradation; and the citrate cycle. Treatment of mice with fecal bacteria from individuals with DS or Prevotella copri significantly altered behaviors often seen in individuals with DS, such as depression-associated behavior and impairment of motor function. These studies suggest that changes in intestinal microbiota and the fecal metabolome are correlated with chronic inflammation and behavior disorders associated with DS. Frontiers Media S.A. 2023-02-23 /pmc/articles/PMC9998045/ /pubmed/36910172 http://dx.doi.org/10.3389/fmicb.2023.1016872 Text en Copyright © 2023 Cai, Lin, Li, Liu, Feng, Zhang, Zhang, Huang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Cai, Shaoli Lin, Jinxin Li, Zhaolong Liu, Songnian Feng, Zhihua Zhang, Yangfan Zhang, Yanding Huang, Jianzhong Chen, Qi Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title | Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title_full | Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title_fullStr | Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title_full_unstemmed | Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title_short | Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice |
title_sort | alterations in intestinal microbiota and metabolites in individuals with down syndrome and their correlation with inflammation and behavior disorders in mice |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998045/ https://www.ncbi.nlm.nih.gov/pubmed/36910172 http://dx.doi.org/10.3389/fmicb.2023.1016872 |
work_keys_str_mv | AT caishaoli alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT linjinxin alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT lizhaolong alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT liusongnian alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT fengzhihua alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT zhangyangfan alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT zhangyanding alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT huangjianzhong alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice AT chenqi alterationsinintestinalmicrobiotaandmetabolitesinindividualswithdownsyndromeandtheircorrelationwithinflammationandbehaviordisordersinmice |